Myocarditis in 12-15-year-old Pfizer recipients in Israel

Publicly released:
International
Pexels on pixabay
Pexels on pixabay

For 12 to 15-year-olds, the risk of myocarditis after the Pfizer shot is higher in boys than girls, according to Israeli researchers who calculated the risk in adolescents using nationwide data. The team used data from the Israeli Ministry of Health on over 400,000 adolescents and found that the risk of myocarditis is 1 case per 12,361 for boys and 1 case per 144,439 for girls. The team note that this is much higher than estimates for unvaccinated people, is lower than previously reported for males between 16 to 24 but higher than the Centres for Disease Control and Prevention's estimate for 12 to 17-year-olds.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page
Journal/
conference:
NEJM
Research:Paper
Organisation/s: Israeli Ministry of Health, Israel
Funder: Pfizer–BioNTech had no role in the collection or analysis of the data or in the reporting of data in this letter.
Media Contact/s
Contact details are only visible to registered journalists.